|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/16 | |||
| A61K 31/55 | |||
| A61K 9/14 |
| (11) | Patento numeris | 2941242 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13829043.2 |
| Europos patento paraiškos padavimo data | 2013-12-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-02-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/085355 |
| Data | 2013-12-27 |
| (87) | Numeris | WO 2014/104412 |
| Data | 2014-07-03 |
| (30) | Numeris | Data | Šalis |
| 201261747005 P | 2012-12-28 | US |
| (72) |
KANEKO, Daiki, JP
MATSUDA, Takakuni, JP
MIYATA, Kenichi, JP
SUZUKI, Kai, JP
FUJIKI, Hiroyuki, JP
KINOSHITA, Shizuo, JP
OHMOTO, Koji, JP
AIHARA, Miki, JP
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |
| INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |